Evonikto expand its ThreAmino capacity in Europe

The nameplate capacity is expected to be expanded to 30,000 metric tonnes L-threonine (feed grade 98.5%) per annum, which represents an increase of 10,000 metric tonnes. The new capacity is scheduled to come on stream in the third quarter of 2013. The additional quantities shall serve the growing demand.

 

“This expansion will transform the Hungarian site into a world-scale plant with state-of-the-art technology.” explains Dr Walter Pfefferle, head of Bioproducts business line of Evonik.

 

The ThreAmino expansion complements two recent expansion announcements by Evonik, namely the construction of a new 150,000 metric tonne MetAmino (DL-methionine) production complex on Jurong Island, Singapore, which is scheduled to come on stream in 2014, and the expansion of Biolys (L-lysine source) to an annual capacity of 280,000 metric tonnes in Blair, Nebraska, USA, by the end of 2012.

 

L-Threonine, which Evonik is marketing under the brand name ThreAmino, is an essential amino acid that cannot be synthesized by the body and therefore needs to be ingested by the animal with the feed. An optimal L-threonine content enhances feed intake, weight gain and the nutritional value of the feed, while nitrogen excretion is reduced by balancing the dietary crude protein content to the animal’s requirement.

 

Evonik is the only company in the world that produces and markets all four essential amino acids used in advanced animal nutrition.